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Abstract
Background: In the inpatient rehabilitation of older patients, estimating to what extent the patient may
functionally recover (functional prognosis), is important to plan the rehabilitation programme and aid discharge
planning. Comorbidity is very common in older patients. However, the role of comorbidity in making a functional
prognosis is not clearly defined. The aim of this study was to investigate a modified and weighted Functional
Comorbidity Index (w-FCI) in relation to functional recovery and compare its predictive performance with that of
the Charlson comorbidity index (CCI) and the original Functional Comorbidity Index (FCI).
Methods: The COOPERATION study (Comorbidity and Outcomes of Older Patients Evaluated in RehabilitATION) is a
prospective observational cohort study. Data of patients that were admitted in an inpatient geriatric rehabilitation
facility in the UK between January and September 2017, were collected. The outcome measures were: the Elderly
Mobility Scale (EMS) and Barthel index (BI) at discharge, EMS gain/day and BI gain/day. Baseline comorbidity was
assessed using the CCI, the FCI and the w-FCI. Correlations, receiver operating curves (ROC), and multiple linear
regression analyses were performed. The models were adjusted for age, gender and EMS or BI on admission.
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Results: In total, 98 patients (mean age 82 years; 37% male) were included. The areas under the ROC curves of the
w-FCI (EMS at discharge: 0.72, EMS gain/day: 0.72, BI at discharge: 0.66 and BI gain/day: 0.60) were higher than for
the CCI (0.50, 0.53, 0.49, 0.44 respectively) and FCI (0.65, 0.55, 0.60, 0.49 respectively). The w-FCI was independently
associated with EMS at discharge (20.7% of variance explained (PVE), p < 0.001), EMS gain/day (11.2PVE, p < 0.001),
and BI at discharge (18.3 PVE, p < 0.001). The FCI was only associated with EMS gain/day (3.9 PVE, p < 0.05). None of
the comorbidity indices contributed significantly to BI gain/day (w-FCI: 2.4 PVE, p > 0.05).
Conclusions: The w-FCI was predictive of mobility & function at discharge and mobility gain per day, and
outperformed the original FCI and the CCI. The w-FCI could be useful in assessing comorbidity in a personalised
way and aid functional prognosis at the start of rehabilitation.
Background
Making a functional prognosis - estimating to what extent a
patient is able to functionally recover - at the start of re-
habilitation is important for adequate planning of rehabilita-
tion therapy and timely preparation for discharge. The
degree to which recovery can be achieved varies between pa-
tients. This is particularly true for older patients after an
acute and debilitating illness, for example a hip fracture, sep-
sis or delirium. Achieving an adequate functional level that
enables the patient to perform activities of daily living (ADL),
with or without aids and/or home care, is necessary prior to
discharge home. Therefore, mobility and functional recovery
are important outcomes in the rehabilitation of older people.
Many patient-related factors may contribute to suc-
cessful or unsuccessful rehabilitation outcomes. These
can be medical (multi-morbidity, disease severity), func-
tional (premorbid ADL, baseline function) and social
(access to formal care, caregiver availability) [1].
The role of assessing comorbidity in functional prognosis
in older patients is not well understood and different co-
morbidity indices exist [2–4]. Comorbidity can be expected
to contribute to the prediction of functional outcome be-
cause it may increase the risk of intercurrent illnesses and
therefore impede rehabilitation therapy [4–6]. The Charl-
son index (CCI) is one of the most widely used comorbidity
indices [7, 8]. It includes 19 conditions, each assigned a
weight based on their hazard ratio; the total score is the
sum of these weighted scores. The index, however, was ini-
tially developed to predict mortality and not functional out-
come. A number of measures have been designed that may
be better associated with functional outcome. Some of
these are severity weighted, such as the Cumulative Illness
Rating Scale and the Index of Co-Existing Diseases, but
they are complex, require specific training, and the use of a
comprehensive manual [9, 10]. The Functional Comorbid-
ity index (FCI) has been designed specifically in relation to
physical function and is easier and more intuitive to use
[11]. It includes 18 diagnoses, counting their presence or
absence, resulting in a cumulative sum score: the number
of comorbidities. A major limitation is that it does not in-
corporate a severity weighting which could help improve its
accuracy in predicting functional outcome [12]. Further-
more, the index does not include dementia, which is a
prevalent condition that influences functional abilities
among older patients [13]. To investigate a comorbidity
index that is both brief and feasible for use in older patients,
a severity-weighted rating scale was added to the original
FCI and also dementia was added. As such, this modified
and weighted FCI (w-FCI) assesses pre-existent comorbid-
ity (chronic conditions) in combination with its impact on
present function.
The present study aims to compare the performance of
the w-FCI in an older patient population with that of the
original FCI and the CCI in predicting mobility and func-
tional recovery at discharge from geriatric rehabilitation [8].
Methods
Setting and design
A prospective observational cohort study was carried out
as a service improvement project: COOPERATION, Co-
morbidity and Outcomes of Older Patients Evaluated in
RehabilitATION. The setting was a community hospital-
based intermediate care facility that provides inpatient
rehabilitation services for older people: Lings Bar Hos-
pital in Nottingham, UK. The multidisciplinary team
consisted of an advanced nurse practitioner (ANP),
nursing staff, a physician, a speech therapist, a physio-
therapist, an occupational therapist, and a social worker.
Patients
Patients studied were older adults that were referred for
inpatient geriatric rehabilitation. No strict age criterion
was applied, but all patients had multimorbidity, com-
plex medical problems or were ≥ 65 years old. Formal re-
search consent was not required because this study was
conducted as a service improvement project under clin-
ical governance. A sample size of 90 was calculated
based upon a minimum sample size of 50 + 8 k (where
k = the number of predictors), including four predictors
into a linear regression model and assuming a dropout
rate of 10% [14]. Other than the open application of
these prognostic indices, which were known to the
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clinical team, patients received care as usual with no
additional intervention.
Comorbidity assessment
Pre-existent comorbidity was assessed by the physician
or the ANP within the first week of admission using
three different indices: the CCI (Additional file 1), the
FCI (Additional file 2) and the w-FCI (Fig. 1) [15]. The
sum score of the indices represented pre-existent co-
morbidity and not the actual disease for which the pa-
tient had been admitted to the facility.
Outcome measures
Data from routine clinical assessments were collected on
admission and at discharge from the rehabilitation facility.
A physiotherapist completed the two outcome measures.
These measures from routine clinical data were mobility
at discharge as measured with the Elderly Mobility Scale
(EMS), range 0–20 (where higher scores denote greater
mobility, Additional file 3), from which EMS gain/day was
calculated by subtracting EMS on admission from EMS at
discharge and dividing the outcome by the total length of
stay in days. The other outcome was functional depend-
ency at discharge measured with the Barthel index (BI),
Fig. 1 The weighted version of the Functional Comorbidity Index
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range 0–20 (where higher scores denote greater independ-
ence in personal ADL, Additional file 4), from which BI
gain/day was calculated [16, 17]. The EMS measures mo-
bility and the ability to carry out transfers that are neces-
sary for ADL activities while the patient performs 7
different tasks. The total score depends on the level of
help the patient requires to succeed in the tasks. The BI
determines the degree of (physical or verbal) help that a
person needs to perform ADL activities. Gain/day is a
measure that takes account of the fact that the length of
stay of each patient varied, leading to a variable time of re-
covery to which the patient is ‘exposed’.
Other variables
Besides comorbidity, the ANP collected the following data
from routine clinical records in the first week after admis-
sion: age, gender, admission domicile, premorbid BI, pri-
mary diagnosis, cognition measured using the Montreal
Cognitive Assessment (MoCA; range 0–30 where higher
scores denote greater cognitive function) [18]. At dis-
charge, the ANP noted the discharge date (length of stay),
intercurrent diseases and discharge destination.
Statistical analysis
The outcomes were used as continuous variables, except
for ROC analysis. Correlations (Spearman’s rho) were
calculated to test the relation between comorbidity indi-
ces and the functional outcome measures. Correlations
of 0.1–0.3, 0.3–0.5 and > 0.5 were considered small,
medium and large effect sizes respectively [19]. Receiver
operating characteristic curve (ROC) analyses were per-
formed in order to create a plot to visualize the differ-
ences of predictive performance of the co-morbidity
indices. To create the ROC plot, the outcomes were di-
chotomized: the cut off point for the BI was set at 15
and for the EMS at 13 on the base of literature [20–22].
The clinical interpretation of a BI = 15 is mildly disabled
to independent, and EMS = 13 is mildly ADL dependent
to independent. For “gain/day” no clinical interpretation
of a cut off score is available and therefore was set at
their median. Additional ROC curves with different
thresholds (cut-off values at 25th, 50th, and 75th percen-
tiles) were created to analyse the robustness of these re-
sults. These were performed because AUC’s may vary
when different cut-off scores are used. Finally, three
multiple linear regression models per outcome were cre-
ated to compare the R-squared value and percentage of
variance explained (PVE) of the w-FCI with that of the
other indices. At first, simple models were created (co-
morbidity index only), age and gender were then added
to the second models and function on admission was
added to the full models. The areas under the ROC
curves (AUCs), R squared values and PVEs were used to
compare the performance of the comorbidity indices in
relation to the four outcome measures.
Results
Characteristics of patients
Ninety-eight patients were included in the study, between
January and September 2017. Two patients were admitted
directly from home but the remainder was admitted after
acute hospitalisation. Fifty-five (56%) patients were admit-
ted following presentation with a fall - with a fracture
(n = 38) or without fracture (n = 17). Patients’ ages ranged
from 57 to 99 years and 38 (39%) were male. The median
functional level on admission was 5.5 (EMS) and 9 (BI)
and this improved to 11 (EMS) and 14 (BI). The median
length of stay in the rehabilitation facility was 24 days and
functional gain/day was 0.19 (EMS) and 0.18 (BI). In total,
68 (69%) were discharged home. All characteristics are
presented in Table 1.
Comorbidity and functional outcome
The most prevalent comorbidities were arthritis (47%)
and osteoporosis (41%). The median scores were 1 for
the CCI index (range: 0–8), 3 for the FCI (range: 0–9)
and 2 for the w-FCI (range: 0–7). The FCI correlated
with both the CCI (ρ: 0.376, p < 0.001) and the w-FCI
(ρ: 0.497, p < 0.001), but the CCI and the w-FCI were
not significantly correlated (ρ: 0.180, p: 0.076). The FCI
correlated only with EMS at discharge (ρ: − 0.245, p:
0.023). The w-FCI correlated with EMS at discharge (ρ:
− 0.469, p < 0.001), EMS gain/day (ρ: − 0.385, p < 0.001)
and BI at discharge (ρ: − 0.415, p < 0.001), but did not
significantly correlate with BI gain/day (ρ: − 0.125, p:
0.250). The CCI did not correlate significantly (p > 0.10)
with any of the outcomes.
Predictive performance
The ROC curves and corresponding AUCs - with their
95% confidence intervals - are presented in Fig. 2.The
AUCs of the w-FCI were larger than those of the CCI
and the FCI, which applied to all functional outcomes.
This remained true for different cut-off scores, except
for BI gain/day (Additional file 5). In the linear regres-
sion analyses, the CCI did not significantly contribute to
the simple or to the full models (p > 0.05), the FCI only
contributed to EMS gain/day (p = 0.037) but was not in-
dependently associated in the full models. The w-FCI in-
dependently contributed to the prediction of EMS & BI
at discharge (p < 0.01) and EMS gain/day (p < 0.001) but
not to BI gain/day (p = 0.082). These associations were
also statistical significant in the full models. The PVE’s
of included variables - with their 95% confidence inter-
vals - are presented in Table 2.
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Discussion
Main findings
Our key finding was that the modified FCI had a better
predictive performance than the CCI and the original
FCI with regard to EMS and BI at discharge and EMS
gain/day in older patients that underwent geriatric re-
habilitation. The w-FCI had a larger AUC and stronger
correlation with these three outcomes (medium effect
size) than the CCI and FCI. Results were not significant
for BI gain/day. Furthermore, the w-FCI was independ-
ently associated with EMS and BI at discharge and EMS
gain/day, whereas the CCI and FCI were not.
Strengths and limitations
This study has several strengths: we did not apply any
restrictions or exclusion criteria except that all patients
Table 1 Patient characteristics on admission and at discharge
On admission (n = 98) Median (IQR, Q1-Q3) or n (%)
Age 82 (11, 77–88)
Gender (male), n (%) 38 (39)
Admission domicile, n (%)
- Own home (alone) 40 (41)
- Own home with informal caregiver 31 (32)
- Own home, with formal care assistance 25 (26)
- Other 2 (2)
Premorbid BI 17 (5, 15–20)
CCI 1 (2, 1–3)
Original FCI 3 (2, 2–4)
Weighted FCI 2 (2, 1–3)
MoCA score (baseline) 20 (10, 14–24)
EMS on admission 5.5 (4, 4–8)
BI on admission 9 (5, 6–11)
Primary diagnosis category, n (%)
- Fall with fracture(s) 38 (39)
- Fall without fracture 17 (17)
- Infectious disease 15 (15)
- Neurological 7 (7)
- Deconditioning 6 (6)
- Other 15 (15)
At discharge
Length of stay (days) 24 (26, 17–43)
EMS at discharge 11 (6, 8–14)
EMS gain/day 0.20 (0.27, 0.11–0.38)
BI at discharge 14 (5, 11–16)
BI gain/day 0.18 (0.22, 0.08–0.30)
Discharge destination, n (%)
- Own home (alone) 7 (7)
- Own home with informal caregiver 6 (6)
- Own home, with formal care assistance 47 (48)
- Home with health reablement 8 (8)
- Care home 17 (17)
- Transfer to acute hospital (lost to follow up) 3 (3)
- Unknown (missing) 5 (5)
Patients died, n (%) 5 (5)
Abbreviations: MoCA Montreal Cognitive Assessment, EMS Elderly Mobility Scale
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had to be referred for rehabilitation. The study cohort
was characterised by a high age, prevalent comorbidity
and a large drop in mobility and functional capacity after
acute illness: it was a typical population and the study
was conducted in a normal clinical setting [23]. How-
ever, no stroke patients were admitted in the facility:
stroke rehabilitation usually is provided in specific post-
acute stroke rehabilitation facilities.
Furthermore, the design of the w-FCI and its rating scale
is function-based and involves the clinical judgement of the
clinician. This is in contrast to many studies that used an
administration-based method of assessing comorbidity.
Therefore, this prospective study gives insight in the clinical
assessment of severity-weighted comorbidity and its potency
in making a functional prognosis. Finally, we used two differ-
ent rehabilitation impact indices per outcome measure: func-
tion/mobility at discharge and function/mobility gain/day
[24]. Function at discharge is an important rehabilitation
outcome that indicates the functional independence of a pa-
tient, which is necessary for discharge planning. However,
other factors than functional status alone may influence dis-
charge planning such as availability of informal caregivers
and home situation (stairs or ground floor). That is why
EMS and BI gain/day - which is a measure of rehabilitation
efficiency - are also important outcomes with regard to the
functional prognosis and duration of stay.
There were also several limitations. The study cohort was
relatively small and the study was carried out in one facility
where the clinicians that completed the measurements were
not blinded to clinical practice and the course of a patient.
To minimize potential bias, the therapists that performed
the EMS and BI were not aware of the comorbidity indices
and its scores. Therefore, we think it is unlikely that it has af-
fected our results to any major degree. We also did not take
therapy type, duration and intensity into account. Patients
likely received customized therapy, on the basis of their cap-
acity and general condition. A larger multicentre study that
takes account of therapy differences across patients would be
needed to investigate whether the predictive validity of the
w-FCI can be confirmed. It is also important to realise that
Fig. 2 The ROC curves of the four different outcomes
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our findings apply to vulnerable older patients but may not
be generalizable to younger patients with less comorbidity.
One last limitation concerning the study design: our study
did not investigate outcomes like quality of life or other indi-
cators of wellbeing, which are also important outcomes of
rehabilitation.
Furthermore, a limitation of the w-FCI may relate to
what we have stated above as one of its strengths: the w-
FCI assesses comorbidity on the base of the clinician’s
opinion and quantifies this into a rating scale. This may
reduce the reliability and reproducibility due to variability
of opinions about the impact of a comorbid condition.
Lastly, for the ROC analyses of BI or EMS gain/day we
have used the medians as the cut-off. A clinical interpret-
ation of these cut off values is lacking in literature, there-
fore these results have to be interpreted with caution.
However, to give a better insight in all the results from the
ROC analyses plots and AUC’s with different thresholds
are presented in the additional files (Additional file 5).
Findings in context
With regard to mobility, the w-FCI showed higher AUCs than
the other indices and independently contributed to the predic-
tion of mobility and function at discharge and mobility gain/
day. This finding supports the conclusion of other studies that
severity of disease should be included in comorbidity assess-
ment [12, 25–29]. The w-FCI contains information on the im-
pact of disease in the patient’s individual situation and
therefore quantifies severity of comorbidity: a clinical severity
weight. This is in contrast to the method of the design studies
of the CCI and FCI [8, 11]. In these studies a statistical weight
(relative risk and/or beta coefficient) was used and no clinical
severity was added to the index. The statistical weighted count
in the original FCI study did not perform much better, but
the authors discuss the issue that de FCI does not take the se-
verity of diagnoses into consideration. They agree that severity
ratings are likely to provide a better performance, but discuss
the practical problems of severity rating. We believe that it is
an important part of assessing comorbidity in older patients.
In our study, the w-FCI explained almost half of the vari-
ance in three out of the four models (not in BI gain/day).
For research purposes in older patients, the w-FCI seems to
be preferable compared to the CCI and the FCI when func-
tional outcomes are of interest. The CCI has proven to be a
sufficient predictor of mortality and we think that the use
of it should be restricted to studies that investigate mortal-
ity and survival. The FCI has been designed in relation to
function, but has not yet been validated in older patients
(e.g. absence of dementia), which may explain the lower
predictive performance in our study [13].
Regarding the BI, the w-FCI performed sufficiently
(AUC > 0.60) and the other indices were poor. An ex-
planation for the overall stronger associations with mo-
bility (EMS) than with the BI (Table 2) could be that the
EMS is sensitive in detecting change (improvement),
which was found to be stronger compared to that of the
BI [30]. In addition, our study cohort was specifically
characterized by reduced mobility (Table 1).
Interpretation of findings
The present study demonstrated that clinicians were able to
estimate functional impact of comorbid conditions in such a
way that it proved to be an independent factor in predicting
mobility and function at discharge and EMS gain/day. Asses-
sing functionally weighted comorbidity using the rating scale
distinguishes the w-FCI from the CCI and the FCI. It resem-
bles usual clinical rehabilitation practice, in which a clinician
evaluates disease severity, functional impairments and the
potential for successful functional recovery. Using the w-FCI,
this could be carried out in a brief and structured way, for
example as part of comprehensive geriatric assessment. Fi-
nally, the w-FCI seems to fit well into the concept of the
International Classification of Functioning, Disability and
Health, the ICF framework [1]. This framework defines
health by the interactions between conditions, body func-
tions and structures, activities and participation, including
environmental and personal factors (Additional file 6).
Conclusions
The w-FCI had higher predictive performance in relation to
functional recovery and efficiency of recovery than the CCI
and the original FCI, especially when measured using the
EMS. The w-FCI may aid in assessing comorbidity in a perso-
nalised way and could be incorporated into routine triaging
and discharge planning in the rehabilitation practice of older
patients. However, further research is required to investigate
whether the predictive validity of the w-FCI can be confirmed.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12877-020-1498-z.
Additional file 1. The Charlson comorbidity index: lay out of the
Charlson comorbidity index.
Additional file 2. The original functional comorbidity index: lay out of
the original functional comorbidity index.
Additional file 3. The Elderly Mobility Scale: content of the Elderly
Mobility Scale.
Additional file 4. The Barthel index: content of the Barthel index.
Additional file 5. Robustness ofd ROC curves: ROC curves of the four
different outcome measures with different thresholds (25th, 50th and
75th percentiles as cut-off scores) to present the robustness of the
results.
Additional file 6. The ICF framework: the w-FCI embedded in the ICF
framework.
Abbreviations
ADL: Activities of daily living; ANP: Advanced nurse practitioner; AUC: Area
under the curve; BI: Barthel index; CCI: Charlson Comorbidity Index;
EMS: Elderly mobility scale; FCI: Functional comorbidity index;
ICF: International Classification of Functioning, Disability and Health;
Kabboord et al. BMC Geriatrics          (2020) 20:114 Page 8 of 9
MoCA: Montreal Cognitive Assessment; PVE: Percentage of Variance
Explained; ROC: Receiver operating characteristic; w-FCI: Weighted functional
comorbidity index
Acknowledgements
The authors thank Nan van Geloven for statistical consultation.
Authors’ contributions
AK, DG, ALG and JRFG made substantial contributions to conception and
design, data collection and acquisition of data. AK conducted the analyses
and drafted the manuscript. ALG, JRFG, MvE, RvB and WPA made substantial
contributions to the design, analysis and interpretation of the data and also
have been involved in revising the manuscript critically for its content. All
authors read and approved of the final manuscript.
Funding
No formal funding or grants were received. The work was supported by
Laurens, a Dutch care organization in Rotterdam, the Netherlands. Laurens
did not play any role in the design of the study, data collection, analysis,
interpretation of the data, and in writing the manuscript.
Availability of data and materials
The authors confirm that all relevant data are included in the article or its
supplementary information files.
Ethics approval and consent to participate
After consultation with the NHS Health Research Authority, this study was
approved by the responsible NHS Trust (Nottinghamshire Healthcare NHS
Trust) as a service improvement project conducted under clinical
governance. No formal ethics approval was required and the
Nottinghamshire Healthcare NHS Trust waived the need for consent.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1Department of Public Health and Primary Care, Leiden University Medical
Center, Hippocratespad 21, Postbus 9600, 2300, RC, Leiden, the Netherlands.
2Lings Bar Hospital, Nottingham Healthcare NHS Trust, Nottingham, UK.
3Division of Medical Sciences and Graduate Entry Medicine, University of
Nottingham, Nottingham, UK. 4Nottingham Biomedical Research Centre,
University of Nottingham, Nottingham, UK. 5CLAHRC East Midlands,
Nottingham, UK. 6University Hospitals of Derby and Burton University
Hospitals NHS Foundation Trust, Derby, UK. 7Nottingham University Hospitals
NHS Trust, Nottingham, UK. 8Department of Old-Age Medicine Hubertusduin,
HMC Bronovo, The Hague, the Netherlands.
Received: 10 October 2019 Accepted: 27 February 2020
References
1. Gladman JR. The international classification of functioning, disability and
health and its value to rehabilitation and geriatric medicine. J Chin Med
Assoc. 2008;71(6):275–8.
2. Spruit-van Eijk EM, Zuidema SU, Buijck BI, Koopmans RT, Geurts AC. To what
extent can multimorbidity be viewed as a determinant of postural control
in stroke patients? Arch Phys Med. 2012;93(6):1021–6.
3. Spruit-van Eijk EM, Zuidema SU, Buijck BI, Koopmans RT, Geurts AC.
Determinants of rehabilitation outcome in geriatric patients admitted to
skilled nursing facilities after stroke: a Dutch multi-Centre cohort study. Age
Ageing. 2012;41(6):746–52.
4. Lew HL, Lee E, Date ES, Zeiner H. Influence of medical comorbidities and
complications on FIM change and length of stay during inpatient
rehabilitation. Am J Phys Med Rehabil. 2002;81(11):830–7.
5. Siegler EL, Stineman MG, Maislin G. Development of complications during
rehabilitation. Arch Intern Med. 1994;154(19):2185–90.
6. Kabboord AD, Van Eijk M, Buijck BI, Koopmans R, van Balen R, Achterberg
WP. Comorbidity and intercurrent diseases in geriatric stroke rehabilitation:
a multicentre observational study in skilled nursing facilities. Eur Geriatr
Med. 2018;9(3):347–53.
7. Yurkovich M, Avina-Zubieta JA, Thomas J, Gorenchtein M, Lacaille D. A
systematic review identifies valid comorbidity indices derived from
administrative health data. J Clin Epidemiol. 2015;68(1):3–14.
8. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying
prognostic comorbidity in longitudinal studies: development and validation.
J Chronic Dis. 1987;40(5):373–83.
9. Salvi F, Miller MD, Grilli A, Giorgi R, Towers AL, Morichi V, et al. A manual of
guidelines to score the modified cumulative illness rating scale and its validation
in acute hospitalized elderly patients. J Am Geriatr Soc. 2008;56(10):1926–31.
10. Imamura K, McKinnon M, Middleton R, Black N. Reliability of a comorbidity measure:
the index of co-existent disease (ICED). J Clin Epidemiol. 1997;50(9):1011–6.
11. Groll DL, To T, Bombardier C, Wright JG. The development of a comorbidity index
with physical function as the outcome. J Clin Epidemiol. 2005;58(6):595–602.
12. Kabboord AD, van Eijk M, Fiocco M, van Balen R, Achterberg WP.
Assessment of comorbidity burden and its association with functional
rehabilitation outcome after stroke or hip fracture: a systematic review and
meta-analysis. J Am Med Dir Assoc. 2016;20(16):30306–1.
13. Hoang-Kim A, Busse JW, Groll D, Karanicolas PJ, Schemitsch E. Co-
morbidities in elderly patients with hip fracture: recommendations of the
ISFR-IOF hip fracture outcomes working group. Arch Orthop Trauma Surg.
2014;134(2):189–95.
14. Green SB. How many subjects does it take to do a regression analysis.
Multivariate Behav Res. 1991;26(3):499–510.
15. Kabboord AD, van Eijk M, van Dingenen L, Wouters M, Koet M, van Balen R,
et al. Reliability and usability of a weighted version of the functional
comorbidity index. Clin Interv Aging. 2019;11(14):289–99.
16. Prosser L, Canby A. Further validation of the elderly mobility scale for
measurement of mobility of hospitalized elderly people. Clin Rehabil. 1997;
11(4):338–43.
17. Collin C, Wade DT, Davies S, Horne V. The Barthel ADL index: a reliability
study. Int Disabil Stud. 1988;10(2):61–3.
18. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I,
et al. The Montreal cognitive assessment, MoCA: a brief screening tool for
mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.
19. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. New
York: Lawrence Erlbaum Associates; 1988.
20. Wade DT, Hewr RL. Functional abilities after stroke: measurement, natural
history and prognosis. J Neurol Neurosurg Psychiatry. 1987;50:177–82.
21. Smith R. Validation and reliability of the elderly mobility scale.
Physiotherapy. 1994;80(11):744–7.
22. Simundic AM. Measures of diagnostic accuracy: basic definitions. EJIFCC.
2009;19(4):203–11.
23. National Audit of Intermediate Care (NAIC). Summary Report – England 2017.
https://s3.eu-west-2.amazonaws.com/nhsbn-static/NAIC+(Providers)/2017/
NAIC+England+Summary+Report+−+upload+2.pdf. Accessed 20 Aug 2018.
24. Koh GC, Chen CH, Petrella R, Thind A. Rehabilitation impact indices and their
independent predictors: a systematic review. BMJ Open. 2013;3(9):e003483.
25. Ferriero G, Franchignoni F, Benevolo E, Ottonello M, Scocchi M, Xanthi M.
The influence of comorbidities and complications on discharge function in
stroke rehabilitation inpatients. Eura Medicophys. 2006;42(2):91–6.
26. Rozzini R, Frisoni GB, Ferrucci L, Barbisoni P, Sabatini T, Ranieri P, et al.
Geriatric index of comorbidity: validation and comparison with other
measures of comorbidity. Age Ageing. 2002;31(4):277–85.
27. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity: a
critical review of available methods. J Clin Epidemiol. 2003;56(3):221–9.
28. Bayliss EA, Ellis JL, Steiner JF. Subjective assessments of comorbidity
correlate with quality of life health outcomes: initial validation of a
comorbidity assessment instrument. Health Qual Life Outcomes. 2005;3:51.
29. Liu M, Domen K, Chino N. Comorbidity measures for stroke outcome
research: a preliminary study. Arch Phys Med Rehabil. 1997;78(2):166–72.
30. Spilg EG, Martin BJ, Mitchell SL, Aitchison TC. A comparison of mobility
assessments in a geriatric day hospital. Clin Rehabil. 2001;15(3):296–300.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Kabboord et al. BMC Geriatrics          (2020) 20:114 Page 9 of 9
